165 related articles for article (PubMed ID: 33344459)
1. Integrated Analysis of a Competing Endogenous RNA Network Reveals a Prognostic Signature in Kidney Renal Papillary Cell Carcinoma.
He R; Wang L; Li J; Ma L; Wang F; Wang Y
Front Cell Dev Biol; 2020; 8():612924. PubMed ID: 33344459
[TBL] [Abstract][Full Text] [Related]
2. Prognostic risk signature based on the expression of three m6A RNA methylation regulatory genes in kidney renal papillary cell carcinoma.
Sun Z; Jing C; Xiao C; Li T; Wang Y
Aging (Albany NY); 2020 Nov; 12(21):22078-22094. PubMed ID: 33177247
[TBL] [Abstract][Full Text] [Related]
3. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
4. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
[TBL] [Abstract][Full Text] [Related]
5. Survival prediction of kidney renal papillary cell carcinoma by comprehensive LncRNA characterization.
Lan H; Zeng J; Chen G; Huang H
Oncotarget; 2017 Dec; 8(67):110811-110829. PubMed ID: 29340018
[TBL] [Abstract][Full Text] [Related]
6. Integrated analysis of long noncoding RNA associated-competing endogenous RNA as prognostic biomarkers in clear cell renal carcinoma.
Yin H; Wang X; Zhang X; Wang Y; Zeng Y; Xiong Y; Li T; Lin R; Zhou Q; Ling H; Zhou F; Zhou Y
Cancer Sci; 2018 Oct; 109(10):3336-3349. PubMed ID: 30152187
[TBL] [Abstract][Full Text] [Related]
7. Construction autophagy-related prognostic risk signature combined with clinicopathological validation analysis for survival prediction of kidney renal papillary cell carcinoma patients.
Fei H; Chen S; Xu C
BMC Cancer; 2021 Apr; 21(1):411. PubMed ID: 33858375
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Analyses of Mutation-Derived Long-Chain Noncoding RNA Signatures of Genome Instability in Kidney Renal Papillary Cell Carcinoma.
Li J; Wei S; Zhang Y; Lu S; Zhang X; Wang Q; Yan J; Yang S; Chen L; Liu Y; Huang Z
Front Genet; 2022; 13():874673. PubMed ID: 35547247
[No Abstract] [Full Text] [Related]
9. Role of anoikis-related gene PLK1 in kidney renal papillary cell carcinoma: a bioinformatics analysis and preliminary verification on promoting proliferation and migration.
Gan L; Xiao Q; Zhou Y; Fu Y; Tang M
Front Pharmacol; 2023; 14():1211675. PubMed ID: 37456749
[No Abstract] [Full Text] [Related]
10. Integrated Analysis of lncRNA-Mediated ceRNA Network Reveals a Prognostic Signature for Hepatocellular Carcinoma.
Sun JR; Kong CF; Xiao KM; Yang JL; Qu XK; Sun JH
Front Genet; 2020; 11():602542. PubMed ID: 33381151
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analyses Revealed Eight Immune Related Signatures Correlated With Aberrant Methylations as Prognosis and Diagnosis Biomarkers for Kidney Renal Papillary Cell Carcinoma.
Luo Y; Chen D; Xing XL
Clin Genitourin Cancer; 2023 Oct; 21(5):537-545. PubMed ID: 37455213
[TBL] [Abstract][Full Text] [Related]
12. Anti-Tumor Role of CAMK2B in Remodeling the Stromal Microenvironment and Inhibiting Proliferation in Papillary Renal Cell Carcinoma.
Jia Q; Liao X; Zhang Y; Xu B; Song Y; Bian G; Fu X
Front Oncol; 2022; 12():740051. PubMed ID: 35127542
[TBL] [Abstract][Full Text] [Related]
13. Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma.
Xie T; Liu B; Liu D; Zhou Y; Yang Q; Wang D; Tang M; Liu W
Front Pharmacol; 2022; 13():1103986. PubMed ID: 36618928
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Analysis of a Competing Endogenous RNA Network Identifies Seven-lncRNA Signature as a Prognostic Biomarker for Melanoma.
Liu N; Liu Z; Liu X; Chen H
Front Oncol; 2019; 9():935. PubMed ID: 31649871
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatic analysis highlights SNHG6 as a putative prognostic biomarker for kidney renal papillary cell carcinoma.
Liu Y; Cheng X; Xi P; Zhang Z; Sun T; Gong B
BMC Urol; 2023 Apr; 23(1):54. PubMed ID: 37004005
[TBL] [Abstract][Full Text] [Related]
16. Construction of immune-related risk signature for renal papillary cell carcinoma.
Wang Z; Song Q; Yang Z; Chen J; Shang J; Ju W
Cancer Med; 2019 Jan; 8(1):289-304. PubMed ID: 30516029
[TBL] [Abstract][Full Text] [Related]
17. High PAQR4 mRNA Expression May Play a Key Role in Prognosis of Kidney Renal Papillary Cell Carcinoma.
Liu C; Cai W; Tang P; Li C
Ann Clin Lab Sci; 2023 Sep; 53(5):701-711. PubMed ID: 37945022
[TBL] [Abstract][Full Text] [Related]
18. Identification of a universal 6-lncRNA prognostic signature for three pathologic subtypes of renal cell carcinoma.
Zuo S; Wang L; Wen Y; Dai G
J Cell Biochem; 2019 May; 120(5):7375-7385. PubMed ID: 30378181
[TBL] [Abstract][Full Text] [Related]
19. Integrated analysis identifying new lncRNA markers revealed in ceRNA network for tumor recurrence in papillary thyroid carcinoma and build of nomogram.
Chen F; Li Z; Deng C; Yan H
J Cell Biochem; 2019 Dec; 120(12):19673-19683. PubMed ID: 31271223
[TBL] [Abstract][Full Text] [Related]
20. Integrated Bioinformatic Analysis of a Competing Endogenous RNA Network Reveals a Prognostic Signature in Endometrial Cancer.
Xia L; Wang Y; Meng Q; Su X; Shen J; Wang J; He H; Wen B; Zhang C; Xu M
Front Oncol; 2019; 9():448. PubMed ID: 31192139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
